Skip to content

Effects of Sub-Dose esketamine on the Evolution from Hypoactive Emergence Delirium to Postoperative Delirium in Elderly Noncardiac Surgical Patients : A Randomized Controlled Trial

Effects of Sub-Dose esketamine on the Evolution from Hypoactive Emergence Delirium to Postoperative Delirium in Elderly Noncardiac Surgical Patients : A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128295
Enrollment
Unknown
Registered
2026-07-17
Start date
2026-07-17
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Experimental Group:Patients received a slow bolus of low-dose esketamine at a dose of 0.1 mg/kg in the post-anesthesia care unit.
Control Group:The patient was given a slow intravenous bolus of saline of equivalent volume in the post-anesthesia care unit.

Sponsors

The first affiliated hospital of anhui medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age older than 60 years; 2.ASA classification II-III; 3. Patients with elective non-cardiac, non-neurosurgical procedures;

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal preoperative cognitive function (MoCA score = 180 / 100mmHg, history of intracerebral hemorrhage, recent cardiovascular events ( such as myocardial infarction in the past 6 months ), severe circulatory failure or shock decompensation, severe liver and kidney dysfunction, history of hypersensitivity to esketamine, ketamine or preparation excipients; 4.Patients with delayed emergence; 5.Chronic alcohol abuse or psychotropic drug use; 6. Ongoing participation in another clinical trial; 7.Decline to participate in the study and sign the informed consent form;

Design outcomes

Secondary

MeasureTime frame
Resting and exercise NRS score;30-day all-cause mortality rate;Cognitive function one month after surgery;Incidence of severe delirium;Post-operative extubation time;Improvement of disorientation in patients with apathy delirium during postoperative emergence period;Sleep quality score;The sum of the number of delirium-positive days in patients with delirium;Cumulative occurrence of POD;Duration of delirium;Postoperative anxiety-depression score;Incidence of complications after surgery;Time from the end of the operation to the appearance of delirium;Length of Stay after surgery;Postoperative cognitive impairment (POCD) on the 5th day after surgery or at the time of discharge (if earlier);

Primary

MeasureTime frame
Incidence of Hypoactive Emergence Delirium;Incidence of postoperative delirium;

Countries

China

Contacts

Public ContactCheng Xinqi

The first affiliated hospital of anhui medical university

ay_mz_cheng@126.com+86 551 62922344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026